Breaking News Instant updates and real-time market news.

NBIX

Neurocrine

$45.00

-1.58 (-3.39%)

, TEVA

Teva

$44.56

-0.48 (-1.07%)

06:27
10/12/16
10/12
06:27
10/12/16
06:27

Neurocrine recent selloff a buying opportunity, says Leerink

Leerink analyst Paul Matteis views the 18% pullback in shares of Neurocrine Biosciences (NBIX) over the past few weeks as a buying opportunity. The analyst finds the catalyst for the selloff "difficult to pinpoint," but notes he's been receiving questions from investors on the size of the market opportunity for vesicular monoamine transporters in Tardive Dyskinesia. A doctor survey suggests a target market of 300,000 TD patients for Neurocrine's and Teva's VMAT2 inhibitors, which is enough to offer a "significant revenue opportunity" for both drugs, Matteis tells investors in a research note. Further, the analyst believes the upcoming Phase II data in Tourette's Syndrome, which he sees as having a high probability of success, offers a "nice catalyst for investors" into Q1 of next year. Matteis reiterates an Outperform rating on Neurocrine with a $70 price target.

NBIX

Neurocrine

$45.00

-1.58 (-3.39%)

TEVA

Teva

$44.56

-0.48 (-1.07%)

  • 06

    Nov

  • 15

    Nov

  • 14

    Dec

NBIX Neurocrine
$45.00

-1.58 (-3.39%)

06/29/16
HCWC
06/29/16
INITIATION
Target $80
HCWC
Buy
Neurocrine initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Andrew Fein started Neurocrine Biosciences with a Buy rating and $80 price target.
09/23/16
LEER
09/23/16
NO CHANGE
LEER
Outperform
Positive data paves way for Teva SD-809 indication, says Leerink
Leerink analyst Jason Gerberry says the AIM-TD study readout clinically de-risks Teva's (TEVA) SD-809 opportunity for tardive dyskinesia, with the investor focus shifting to market size and competitive differentiation versus Neurocrine's (NBIX) valbenazine. The analyst believes Teva's SD-809 is well positioned to compete against valbenazine with an equally efficacious and well tolerated drug. Further, he expects Teva to exit 2017 with a broader label. Gerberry reiterates an Outperform rating on Teva's shares.
10/04/16
LEER
10/04/16
INITIATION
Target $70
LEER
Outperform
Neurocrine reinstated with an Outperform at Leerink
Leerink analyst Paul Matteis resumed coverage of Neurocrine with an Outperform rating and $70 price target.
10/06/16
LEHM
10/06/16
DOWNGRADE
Target $50
LEHM
Equal Weight
Alnylam downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Geoff Meacham downgraded Alnylam Pharmaceuticals (ALNY) to Equal Weight saying he views other SMid cap biotech names as more attractive following the company's recent pipeline setbacks. The analyst removed Revusiran sales from his Alnylam model after the program was discontinued yesterday and he cut his price target for the shares to $50 from $85. Meacham lists Neurocrine (NBIX), Prothena (PTRA) and Incyte (INCY) as names he finds more attractive over the next 12 months. Alnylam is trading down 44% in pre-market trading to $39.25.
TEVA Teva
$44.56

-0.48 (-1.07%)

10/05/16
WELS
10/05/16
NO CHANGE
WELS
Outperform
Teva estimates lowered on generic trends at Wells Fargo
Wells Fargo analyst David Maris lowered his estimates for Teva (TEVA) for this year and next, citing expectations for lower generic sales this year and lower margins in the generic business. Maris lowered his price target range for Teva shares to $60-$61 from $70-73 based on his lower estimates as well as the uncertainty of the environment, but keeps an Outperform rating on shares citing valuation and his belief 2017 should be a better year with several pipeline events for Teva.
10/06/16
WELS
10/06/16
NO CHANGE
WELS
Wells calls Teva partnership with Celltrion 'good news'
Wells Fargo analyst David Maris views Teva Pharmaceutical's partnership to commercialize two of Celltrion's monoclonal antibody biosimilar candidates as "good news." Teva is now a "little more firmly in the biosimilar game," Maris tells investors in a research note. He likes that the initial cash outflow is small and the partner. Maris has an Outperform rating on Teva.
10/07/16
LEER
10/07/16
NO CHANGE
Target $57
LEER
Outperform
Teva price target lowered to $57 from $61 at Leerink
Leerink analyst Jason Gerberry lowered his price target for Teva to $57 from $61 and trimmed his estimates to reflect near-term headwinds and a more conservative Copaxone outlook. The analyst continues to view a generic Copaxone launch in late the second half of 2017 as a risk. Nonetheless, Gerberry reiterates an Outperform rating on the stock as he views shares as attractively valued despite near-term EPS concerns and believes investor attention will eventually pivot to Teva's attractive late stage pipeline.
10/11/16
LEHM
10/11/16
UPGRADE
Target $19
LEHM
Overweight
Momenta upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Douglas Tsao upgraded Momenta Pharmaceuticals to Overweight after attending the consolidated Copaxone 40mg trial. The analyst sees low risk of Momenta being blocked from the 40mg opportunity past 2018 and views the stock's risk/reward as "compelling" at current levels. Tsao believes there is a "good likelihood" that Sandoz, Momenta's partner, launches Copaxone 40mg at-risk as soon as February 2017 upon FDA approval when the 30-month stay expires. The analyst raised his price target for Momenta shares to $19 from $13.

TODAY'S FREE FLY STORIES

OGS

One Gas

$68.99

0.08 (0.12%)

16:28
01/16/18
01/16
16:28
01/16/18
16:28
Hot Stocks
One Gas sees FY18 CapEx $375M »

With 70% of these…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 01

    May

  • 31

    Jul

  • 30

    Oct

IDCC

InterDigital

$79.40

-1.3 (-1.61%)

16:28
01/16/18
01/16
16:28
01/16/18
16:28
Hot Stocks
InterDigital in amended patent license pact with Pegatron »

On January 16 certain…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

OGS

One Gas

$68.99

0.08 (0.12%)

16:27
01/16/18
01/16
16:27
01/16/18
16:27
Earnings
ONE Gas raises FY17 EPS view to $3.06-$3.10 from $2.94-$3.04, consensus $3.03 »

Included in the 2017 EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 01

    May

  • 31

    Jul

  • 30

    Oct

INTC

Intel

$43.14

-0.1 (-0.23%)

, AMD

AMD

$11.91

-0.11 (-0.92%)

16:26
01/16/18
01/16
16:26
01/16/18
16:26
Hot Stocks
Rep. McNerney requests briefing from Intel, AMD on security vulnerabilities »

U.S. Representative from…

INTC

Intel

$43.14

-0.1 (-0.23%)

AMD

AMD

$11.91

-0.11 (-0.92%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 25

    Jan

  • 30

    Jan

AMGP

Antero Midstream GP

$21.00

-0.04 (-0.19%)

16:22
01/16/18
01/16
16:22
01/16/18
16:22
Hot Stocks
Antero Midstream GP increases dividend 27% to 7.5c »

The Board of Directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

AM

Antero Midstream Partners

16:21
01/16/18
01/16
16:21
01/16/18
16:21
Hot Stocks
Antero Midstream Partners increases dividend 7% to 36.5c »

The Board of Directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

ESP

Espey Mfg

$24.55

-0.1092 (-0.44%)

16:21
01/16/18
01/16
16:21
01/16/18
16:21
Hot Stocks
Espey Mfg announces new three-year term for CEO Patrick Enright, Jr. »

Espey Mfg. &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QTM

Quantum

$6.07

-0.07 (-1.14%)

, GUID

Guidance Software

16:20
01/16/18
01/16
16:20
01/16/18
16:20
Hot Stocks
Quantum appoints Patrick Dennis as CEO »

Quantum (QTM) announced…

QTM

Quantum

$6.07

-0.07 (-1.14%)

GUID

Guidance Software

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIX

Volatility Index S&P 500 Options

16:20
01/16/18
01/16
16:20
01/16/18
16:20
Options
Closing CBOE SPX and VIX Index summary for January 16th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$335.16

-1.05 (-0.31%)

, ADNT

Adient

$82.18

-0.51 (-0.62%)

16:19
01/16/18
01/16
16:19
01/16/18
16:19
Hot Stocks
Boeing, Adient launch new company to design, build airplane seats »

Boeing (BA) and Adient…

BA

Boeing

$335.16

-1.05 (-0.31%)

ADNT

Adient

$82.18

-0.51 (-0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 29

    Jan

  • 31

    Jan

  • 21

    Feb

CLD

Cloud Peak

$5.31

-0.24 (-4.32%)

16:18
01/16/18
01/16
16:18
01/16/18
16:18
Hot Stocks
Cloud Peak Energy signs long-term coal export pact with JERA Trading »

Cloud Peak Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Feb

GDEN

Golden Entertainment

$31.70

-0.48 (-1.49%)

16:18
01/16/18
01/16
16:18
01/16/18
16:18
Syndicate
Golden Entertainment files to sell 6.5M shares of common stock for holders »

J.P. Morgan and Morgan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATEN

A10 Networks

$7.31

-0.27 (-3.56%)

16:18
01/16/18
01/16
16:18
01/16/18
16:18
Hot Stocks
Breaking Hot Stocks news story on A10 Networks »

A10 Networks down 2%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATEN

A10 Networks

$7.31

-0.27 (-3.56%)

16:17
01/16/18
01/16
16:17
01/16/18
16:17
Earnings
A10 Networks reports preliminary Q4 adjusted EPS 5c-6c, consensus 3c »

Reports preliminary Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMT

Core Molding

$20.85

-0.49 (-2.30%)

16:17
01/16/18
01/16
16:17
01/16/18
16:17
Hot Stocks
Core Molding acquires Horizon Plastics for approximately $63M in cash »

Core Molding announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HIVE

Aerohive

$5.70

-0.19 (-3.23%)

16:17
01/16/18
01/16
16:17
01/16/18
16:17
Earnings
Aerohive cuts Q4 revenue view to roughly $37M from $40M-$42M, consensus $40.89M »

The Company expects…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

16:17
01/16/18
01/16
16:17
01/16/18
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRK

Merck

$62.07

3.41 (5.81%)

, UNH

UnitedHealth

$233.29

4.65 (2.03%)

16:16
01/16/18
01/16
16:16
01/16/18
16:16
General news
On The Fly: Top stock stories for Tuesday »

Stocks opened sharply…

MRK

Merck

$62.07

3.41 (5.81%)

UNH

UnitedHealth

$233.29

4.65 (2.03%)

GE

General Electric

$18.21

-0.55 (-2.93%)

NSRGY

Nestle

$86.20

1.1 (1.29%)

QCOM

Qualcomm

$68.25

2.87 (4.39%)

AVGO

Broadcom

$263.25

-1.04 (-0.39%)

GM

General Motors

$44.19

0.12 (0.27%)

HAWK

Blackhawk

$45.08

8.575 (23.49%)

SCOR

comScore

$24.45

-4.65 (-15.98%)

UAA

Under Armour; also tag UA

$13.82

-1.305 (-8.63%)

UA

Under Armour; also tag UAA

$12.48

-1.665 (-11.78%)

NXPI

NXP Semiconductors

$119.40

-0.18 (-0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 16

    Jan

  • 16

    Jan

  • 18

    Jan

  • 24

    Jan

  • 25

    Jan

  • 31

    Jan

  • 02

    Feb

  • 06

    Feb

  • 08

    Feb

  • 06

    Mar

  • 08

    Mar

  • 25

    Mar

  • 03

    Apr

  • 23

    Apr

  • 23

    Oct

XON

Intrexon

$13.78

-0.935 (-6.36%)

16:16
01/16/18
01/16
16:16
01/16/18
16:16
Syndicate
Intrexon files to sell common stock, no amount given »

JMP Securities LLC is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

16:16
01/16/18
01/16
16:16
01/16/18
16:16
Technical Analysis
NYSE market internals summary »

Volume was above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MET

MetLife

$51.85

-1.48 (-2.78%)

16:16
01/16/18
01/16
16:16
01/16/18
16:16
Hot Stocks
MetLife to merger General American Life with and into Metropolitan Tower »

MetLife announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

  • 12

    Jun

OSTK

Overstock.com

$70.25

-8.7 (-11.02%)

, KODK

Kodak

$8.43

-0.775 (-8.42%)

16:13
01/16/18
01/16
16:13
01/16/18
16:13
Hot Stocks
Overstock's tZERO to trade KODAKCoin on future security token trading platform »

Overstock.com's…

OSTK

Overstock.com

$70.25

-8.7 (-11.02%)

KODK

Kodak

$8.43

-0.775 (-8.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EHTH

eHealth

$17.52

-0.045 (-0.26%)

16:13
01/16/18
01/16
16:13
01/16/18
16:13
Hot Stocks
eHealth CFO David Francis to transition to role of Chief Operating Officer »

eHealth announced changes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EHTH

eHealth

$17.52

-0.045 (-0.26%)

16:12
01/16/18
01/16
16:12
01/16/18
16:12
Earnings
eHealth sees FY17 adjusted EBITDA ($15.5M)-($14.5M) »

Sees FY17 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EHTH

eHealth

$17.52

-0.045 (-0.26%)

16:12
01/16/18
01/16
16:12
01/16/18
16:12
Hot Stocks
eHealth acquires GoMedigap for $20M »

eHealth announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.